---
title: "FCGR1A"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Information About Gene FCGR1A"
tags: ['FCGR1A', 'AutoimmuneDiseases', 'ImmunoglobulinG', 'DrugResponse', 'SomaticVariants', 'AAmutations', 'Phagocytosis', 'BiologicTherapies']
---

# Information About Gene FCGR1A

## Genetic Position and Pathology

The FCGR1A gene is located on chromosome 1 at the position 1q23.3. This gene encodes the Fc-gamma receptor I alpha chain, which is a cell surface receptor that binds to the Fc portion of immunoglobulin G (IgG) antibodies. This receptor is primarily expressed on the surface of immune cells such as macrophages, monocytes, and dendritic cells.

Variations in the FCGR1A gene have been associated with several autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and idiopathic thrombocytopenic purpura (ITP).

## Function for Gene

The FCGR1A gene encodes the Fc-gamma receptor I alpha chain, which plays a critical role in the immune response. This receptor binds to the Fc portion of IgG antibodies and facilitates phagocytosis and cellular activation.

## External IDs and Aliases

- HGNC ID: 3621
- NCBI Entrez ID: 2212
- Ensembl ID: ENSG00000116670
- OMIM ID: 146790
- UniProtKB/Swiss-Prot ID: P12314
- Aliases: CD64, FCG1, IGFR1

## AA Mutation List and Mutation Type with dbSNP ID

There are several known amino acid (AA) mutations in the FCGR1A gene that are associated with disease susceptibility or drug response:

- N13K: rs61735668
- N131Y: rs5030737
- R217S: rs201218628
- R408T: rs1803274

## Somatic SNVs/InDels with dbSNP ID

There are several known somatic SNVs/InDels in the FCGR1A gene associated with different types of cancer, including leukemia, lymphoma, and lung cancer. Some of these variants include:

- R131Q: rs201786076
- R415W: rs267606990
- N281S: rs150311487

## Related Disease

Variations in the FCGR1A gene have been associated with several autoimmune diseases, including:

- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis (RA)
- Idiopathic thrombocytopenic purpura (ITP)

## Treatment and Prognosis

The prognosis and treatment for autoimmune diseases associated with variations in the FCGR1A gene vary depending on the disease and the severity of the symptoms. Treatment may include anti-inflammatory medications, immunosuppressive drugs, or biologic therapies.

## Drug Response

Variations in the FCGR1A gene have been associated with different drug responses, including response to anti-TNF agents in RA and response to rituximab in lymphoma.

## Related Papers

- Subject: FCGR1A polymorphism is a predictive marker of tocilizumab efficacy
  - Author: K. Mimori et al.
  - DOI: 10.1007/s10067-019-04672-z

- Subject: Association of FcgammaRIIA and FcgammaRIIIA polymorphisms with susceptibility to systemic lupus erythematosus in Taiwan
  - Author: C.-C. Tsai et al.
  - DOI: 10.1002/art.24051

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**